Institutional Investor

Updated:

Claudia von Schilling Foundation

The Claudia von Schilling Foundation is an institutional investor headquartered in Zurich, Switzerland. The foundation promotes projects that promise new...

Claudia von Schilling Foundation

The Claudia von Schilling Foundation is an institutional investor headquartered in Zurich, Switzerland. The foundation promotes projects that promise new approaches in breast cancer treatment and related therapeutic measures. Its focus centers on advancing therapeutic innovation within the oncology space, specifically breast cancer. No additional details regarding investment stages, portfolio companies, fund sizes, or assets under management are publicly provided in the available source material.

General information

Firm type

Institutional Investor

Location

Country

Switzerland

City

Zurich

Corporate office

Zurich, Switzerland

Sector focus

Institutional InvestorSwitzerland

Frequently asked questions

What is the Claudia von Schilling Foundation?

It is an institutional investor based in Zurich, Switzerland, that promotes projects promising new approaches in breast cancer treatment and related therapeutic measures.

What therapeutic area does the foundation focus on?

The foundation focuses on breast cancer treatment and related therapeutic measures, supporting projects that offer new approaches in this field.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Zurich Institutional Investor profiles